China’s National Medical Products Administration granted approval for the Genesis robotic magnetic navigation (RNM) system.

Genesis delivers the benefits of robotic precision and safety to cardiac ablation to treat arrhythmias. The system utilizes smaller magnets that rotate along their center of mass, allowing for responsiveness to physician control. Flexible, rugged robotic arms hold the agents to increase the potential range of motion and allow for wider X-ray angulation.

Stereotaxis said the approval marks a significant milestone as it expands access to the minimally invasive robotic technology in China. In 2021, the company inked a collaboration with MicroPort EP, a Shanghai-based firm, for distribution and commercialization in China.